scispace - formally typeset
R

Riad A. Sulimani

Researcher at King Saud University

Publications -  56
Citations -  1838

Riad A. Sulimani is an academic researcher from King Saud University. The author has contributed to research in topics: Diabetes mellitus & Population. The author has an hindex of 17, co-authored 52 publications receiving 1495 citations. Previous affiliations of Riad A. Sulimani include King Khalid University.

Papers
More filters
Journal ArticleDOI

Diagnosis and Management of Osteonecrosis of the Jaw: A Systematic Review and International Consensus

TL;DR: In those patients at high risk for the development of ONJ, including cancer patients receiving high‐dose BP or Dmab therapy, consideration should be given to withholding antiresorptive therapy following extensive oral surgery until the surgical site heals with mature mucosal coverage.
Journal ArticleDOI

Case-Based Review of Osteonecrosis of the Jaw (ONJ) and Application of the International Recommendations for Management From the International Task Force on ONJ

Aliya Khan, +37 more
TL;DR: A case-based review of ONJ and application of the International Task Force recommendations for the diagnosis and management of oncology and osteoporosis patients is provided.
Journal ArticleDOI

Effects of methylcobalamin on diabetic neuropathy.

TL;DR: The active group showed statistical improvement in the somatic and autonomic symptoms with regression of signs of diabetic neuropathy and the drug was easily tolerated by the patients and no side effects were encountered.
Journal ArticleDOI

Vitamin D status correction in Saudi Arabia: an experts’ consensus under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis, and Musculoskeletal Diseases (ESCEO)

TL;DR: A panel that formulated unified recommendations in the diagnosis and treatment of vitamin D deficiency in the region found that vitamin D supplementation/correction is advised in all persons whose serum 25(OH)D falls below 50 nmol/l (20 ng/ml), and achieving a target of 75 nmol /l (30 ng/l) is particularly suited for frail, osteoporotic, and older patients.
Journal ArticleDOI

Diabetes mellitus and Ramadan fasting: the need for a critical appraisal.

TL;DR: The metabolic changes during fasting in healthy individuals are reviewed, the potential risks of fasting to a diabetic patient are assessed, and a few suggestions for the counselling of diabetic patients are offered.